Published in Hum Mol Genet on October 11, 2011
Active human retrotransposons: variation and disease. Curr Opin Genet Dev (2012) 3.60
Differential L1 regulation in pluripotent stem cells of humans and apes. Nature (2013) 2.29
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and disease. Mod Pathol (2013) 1.95
Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells. Cell (2015) 1.58
Active transposition in genomes. Annu Rev Genet (2012) 1.51
Ubiquitous L1 mosaicism in hippocampal neurons. Cell (2015) 1.40
Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency. Genome Res (2014) 1.30
Genomic instability in pluripotent stem cells: implications for clinical applications. J Biol Chem (2013) 1.13
The Microprocessor controls the activity of mammalian retrotransposons. Nat Struct Mol Biol (2013) 1.07
Microarray analysis of LTR retrotransposon silencing identifies Hdac1 as a regulator of retrotransposon expression in mouse embryonic stem cells. PLoS Comput Biol (2012) 1.02
L1 retrotransposons, cancer stem cells and oncogenesis. FEBS J (2013) 0.97
Retrotransposition in tumors and brains. Mob DNA (2014) 0.96
Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells. Retrovirology (2013) 0.96
The Influence of LINE-1 and SINE Retrotransposons on Mammalian Genomes. Microbiol Spectr (2015) 0.96
Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells. Mol Ther (2012) 0.90
Reprogramming triggers endogenous L1 and Alu retrotransposition in human induced pluripotent stem cells. Nat Commun (2016) 0.88
Retroviral transcriptional regulation and embryonic stem cells: war and peace. Mol Cell Biol (2014) 0.88
Transposable elements in the mammalian embryo: pioneers surviving through stealth and service. Genome Biol (2016) 0.86
How retrotransposons shape genome regulation. Curr Opin Genet Dev (2016) 0.85
Retrotransposons shape species-specific embryonic stem cell gene expression. Retrovirology (2015) 0.84
The DNA Habitat and its RNA Inhabitants: At the Dawn of RNA Sociology. Genomics Insights (2013) 0.83
New Trends in Aryl Hydrocarbon Receptor Biology. Front Cell Dev Biol (2016) 0.82
TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells. Genome Biol (2016) 0.82
LINE-1 induces hTERT and ensures telomere maintenance in tumour cell lines. Oncogene (2015) 0.82
miR-128 represses L1 retrotransposition by binding directly to L1 RNA. Nat Struct Mol Biol (2015) 0.81
Transposable elements at the center of the crossroads between embryogenesis, embryonic stem cells, reprogramming, and long non-coding RNAs. Sci Bull (Beijing) (2015) 0.81
Analysis of the human immunodeficiency virus-1 RNA packageome. RNA (2016) 0.81
LINEs of evidence: noncanonical DNA replication as an epigenetic determinant. Biol Direct (2013) 0.80
Upregulated LINE-1 Activity in the Fanconi Anemia Cancer Susceptibility Syndrome Leads to Spontaneous Pro-inflammatory Cytokine Production. EBioMedicine (2016) 0.80
Restricting retrotransposons: a review. Mob DNA (2016) 0.79
Transposable Elements and DNA Methylation Create in Embryonic Stem Cells Human-Specific Regulatory Sequences Associated with Distal Enhancers and Noncoding RNAs. Genome Biol Evol (2015) 0.79
Polycomb binding precedes early-life stress responsive DNA methylation at the Avp enhancer. PLoS One (2014) 0.79
Alu retrotransposons promote differentiation of human carcinoma cells through the aryl hydrocarbon receptor. Nucleic Acids Res (2016) 0.78
Deep sequencing reveals low incidence of endogenous LINE-1 retrotransposition in human induced pluripotent stem cells. PLoS One (2014) 0.78
Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci. Elife (2016) 0.77
Transgene Reactivation in Induced Pluripotent Stem Cell Derivatives and Reversion to Pluripotency of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells. Stem Cells Dev (2016) 0.77
Reversible mitochondrial DNA accumulation in nuclei of pluripotent stem cells. Stem Cells Dev (2014) 0.76
Conservation and Innovation of APOBEC3A Restriction Functions during Primate Evolution. Mol Biol Evol (2016) 0.76
Engineered LINE-1 retrotransposition in non-dividing human neurons. Genome Res (2016) 0.76
Guardian of the Human Genome: Host Defense Mechanisms against LINE-1 Retrotransposition. Front Chem (2016) 0.75
Senescence Meets Dedifferentiation. Plants (Basel) (2015) 0.75
Transposable elements and miRNA: Regulation of genomic stability and plasticity. Mob Genet Elements (2016) 0.75
Deciphering fact from artifact when using reporter assays to investigate the roles of host factors on L1 retrotransposition. Mob DNA (2016) 0.75
Cell-host, LINE and environment: Three players in search of a balance. Mob Genet Elements (2013) 0.75
Heritable L1 retrotransposition in the mouse primordial germline and early embryo. Genome Res (2017) 0.75
Dynamic silencing of somatic L1 retrotransposon insertions reflects the developmental and cellular contexts of their genomic integration. Mob DNA (2017) 0.75
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Induced pluripotent stem cell lines derived from human somatic cells. Science (2007) 71.50
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Cytosine methylation and the ecology of intragenomic parasites. Trends Genet (1997) 13.66
A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol (2007) 13.56
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
High frequency retrotransposition in cultured mammalian cells. Cell (1996) 8.60
Copy number variation and selection during reprogramming to pluripotency. Nature (2011) 8.24
Human L1 retrotransposon encodes a conserved endonuclease required for retrotransposition. Cell (1996) 8.21
The impact of retrotransposons on human genome evolution. Nat Rev Genet (2009) 8.08
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol (2008) 7.91
Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L. Nature (2004) 7.57
LINE-mediated retrotransposition of marked Alu sequences. Nat Genet (2003) 7.32
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature (2005) 6.95
Human LINE retrotransposons generate processed pseudogenes. Nat Genet (2000) 6.64
Many human L1 elements are capable of retrotransposition. Nat Genet (1997) 6.27
Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A (2003) 6.16
Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man. Nature (1988) 6.01
Natural mutagenesis of human genomes by endogenous retrotransposons. Cell (2010) 5.50
Human L1 retrotransposition: cis preference versus trans complementation. Mol Cell Biol (2001) 5.23
Genomic deletions created upon LINE-1 retrotransposition. Cell (2002) 4.92
Sequence patterns indicate an enzymatic involvement in integration of mammalian retroposons. Proc Natl Acad Sci U S A (1997) 4.80
Human l1 retrotransposition is associated with genetic instability in vivo. Cell (2002) 4.79
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
LINE-1 retrotransposition activity in human genomes. Cell (2010) 4.60
Retrotransposons revisited: the restraint and rehabilitation of parasites. Cell (2008) 4.19
Unit-length line-1 transcripts in human teratocarcinoma cells. Mol Cell Biol (1988) 3.99
QUMA: quantification tool for methylation analysis. Nucleic Acids Res (2008) 3.73
Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Determination of L1 retrotransposition kinetics in cultured cells. Nucleic Acids Res (2000) 2.84
Mammalian non-LTR retrotransposons: for better or worse, in sickness and in health. Genome Res (2008) 2.83
The human LINE-1 retrotransposon creates DNA double-strand breaks. J Mol Biol (2006) 2.77
Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol (2005) 2.77
L1 retrotransposition occurs mainly in embryogenesis and creates somatic mosaicism. Genes Dev (2009) 2.68
RNA truncation by premature polyadenylation attenuates human mobile element activity. Nat Genet (2003) 2.40
A mouse model of human L1 retrotransposition. Nat Genet (2002) 2.39
Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat Struct Mol Biol (2006) 2.23
Progress in understanding the biology of the human mutagen LINE-1. Hum Mutat (2007) 2.17
LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet (2007) 2.13
L1 retrotransposition can occur early in human embryonic development. Hum Mol Genet (2007) 2.04
Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum Mol Genet (2005) 2.02
Hypomethylation of retrotransposable elements correlates with genomic instability in non-small cell lung cancer. Int J Cancer (2009) 1.94
Translation of LINE-1 DNA elements in vitro and in human cells. Proc Natl Acad Sci U S A (1990) 1.93
LINE drive. retrotransposition and genome instability. Cell (2002) 1.92
Retracted Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia. Oncogene (2005) 1.91
Tightly regulated, developmentally specific expression of the first open reading frame from LINE-1 during mouse embryogenesis. Proc Natl Acad Sci U S A (1995) 1.90
Synchronous expression of LINE-1 RNA and protein in mouse embryonal carcinoma cells. Mol Cell Biol (1993) 1.81
L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci U S A (2006) 1.73
Alu repeat discovery and characterization within human genomes. Genome Res (2010) 1.62
Somatic expression of LINE-1 elements in human tissues. Nucleic Acids Res (2010) 1.61
L1 mobile element expression causes multiple types of toxicity. Gene (2008) 1.60
Human LINE-1 retrotransposon induces DNA damage and apoptosis in cancer cells. Cancer Cell Int (2006) 1.59
Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet (2010) 1.56
Evidence consistent with human L1 retrotransposition in maternal meiosis I. Am J Hum Genet (2002) 1.56
Mobile element scanning (ME-Scan) by targeted high-throughput sequencing. BMC Genomics (2010) 1.54
A potential role for the nucleolus in L1 retrotransposition. Hum Mol Genet (2004) 1.53
Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase. Genome Res (2007) 1.50
Tracking an embryonic L1 retrotransposition event. Proc Natl Acad Sci U S A (2003) 1.49
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature (2010) 1.47
The human genome contains many types of chimeric retrogenes generated through in vivo RNA recombination. Nucleic Acids Res (2003) 1.38
LINE dancing in the human genome: transposable elements and disease. Genome Med (2009) 1.33
A modified indicator gene for selection of retrotransposition events in mammalian cells. Biotechniques (1994) 1.27
The impact of multiple splice sites in human L1 elements. Gene (2008) 1.26
Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol Cell Biol (2010) 1.14
Cell divisions are required for L1 retrotransposition. Mol Cell Biol (2006) 1.13
Nucleoside analogue reverse transcriptase inhibitors differentially inhibit human LINE-1 retrotransposition. PLoS One (2008) 1.11
Human-induced pluripotent stem cells produced under xeno-free conditions. Stem Cells Dev (2010) 1.04
Retrotransposon RNA expression and evidence for retrotransposition events in human oocytes. Hum Mol Genet (2009) 0.99
The challenge of finding a cure for HIV infection. Science (2009) 8.41
HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell (2003) 7.42
Somatic mosaicism in neuronal precursor cells mediated by L1 retrotransposition. Nature (2005) 6.95
Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol (2004) 6.88
Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci U S A (2003) 6.16
A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. Nat Biotechnol (2002) 5.49
Retracted Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells. Nature (2005) 5.28
Genomic deletions created upon LINE-1 retrotransposition. Cell (2002) 4.92
Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB. EMBO J (2002) 4.91
L1 retrotransposition in human neural progenitor cells. Nature (2009) 4.78
LINE-1 retrotransposition activity in human genomes. Cell (2010) 4.60
DNA repair mediated by endonuclease-independent LINE-1 retrotransposition. Nat Genet (2002) 4.58
NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J (2005) 4.35
The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements. Annu Rev Immunol (2008) 4.27
HIV vaccine research: the way forward. Science (2008) 3.86
Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 3.76
Mobile elements and mammalian genome evolution. Curr Opin Genet Dev (2003) 3.68
NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol (2005) 3.50
Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell (2010) 3.42
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
HIV latency. Cold Spring Harb Perspect Med (2011) 2.90
Multiple fates of L1 retrotransposition intermediates in cultured human cells. Mol Cell Biol (2005) 2.77
IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science (2013) 2.68
Dynamic interactions between transposable elements and their hosts. Nat Rev Genet (2011) 2.61
High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc Natl Acad Sci U S A (2006) 2.54
Prostratin antagonizes HIV latency by activating NF-kappaB. J Biol Chem (2004) 2.47
A comprehensive analysis of recently integrated human Ta L1 elements. Am J Hum Genet (2002) 2.47
LINE-1 elements in structural variation and disease. Annu Rev Genomics Hum Genet (2011) 2.42
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis. Neurology (2014) 2.41
The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol (2007) 2.41
The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection. J Virol (2008) 2.38
Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell (2013) 2.28
Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles. Nat Struct Mol Biol (2006) 2.23
Phosphorylated positive transcription elongation factor b (P-TEFb) is tagged for inhibition through association with 7SK snRNA. J Biol Chem (2003) 2.21
LINE-1 retrotransposition in human embryonic stem cells. Hum Mol Genet (2007) 2.13
Active Alu retrotransposons in the human genome. Genome Res (2008) 2.09
Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J Virol (2004) 2.06
Tat competes with HEXIM1 to increase the active pool of P-TEFb for HIV-1 transcription. Nucleic Acids Res (2007) 2.02
Ribonucleoprotein particle formation is necessary but not sufficient for LINE-1 retrotransposition. Hum Mol Genet (2005) 2.02
p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1. J Biol Chem (2004) 2.01
ATLAS: a system to selectively identify human-specific L1 insertions. Am J Hum Genet (2003) 2.00
Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science (2008) 1.97
Guidelines for naming nonprimate APOBEC3 genes and proteins. J Virol (2008) 1.86
Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres. Nature (2007) 1.84
Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. J Mol Med (Berl) (2003) 1.79
Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J Exp Med (2006) 1.77
Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Malar J (2007) 1.76
Selective inhibition of Alu retrotransposition by APOBEC3G. Gene (2006) 1.75
Sustained induction of NF-kappa B is required for efficient expression of latent human immunodeficiency virus type 1. J Virol (2007) 1.74
L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci U S A (2006) 1.73
Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection. Cell Host Microbe (2011) 1.72
Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology (2010) 1.70
Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS Pathog (2007) 1.70
In vitro derived dendritic cells trans-infect CD4 T cells primarily with surface-bound HIV-1 virions. PLoS Pathog (2007) 1.70
Distinct patterns of cytokine regulation of APOBEC3G expression and activity in primary lymphocytes, macrophages, and dendritic cells. J Biol Chem (2006) 1.68
An integrated overview of HIV-1 latency. Cell (2013) 1.68
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci U S A (2012) 1.65
A YY1-binding site is required for accurate human LINE-1 transcription initiation. Nucleic Acids Res (2004) 1.59
Unconventional translation of mammalian LINE-1 retrotransposons. Genes Dev (2006) 1.58
Characterization of LINE-1 ribonucleoprotein particles. PLoS Genet (2010) 1.56
Distinct mechanisms for trans-mediated mobilization of cellular RNAs by the LINE-1 reverse transcriptase. Genome Res (2007) 1.50
Regulation of HIV-1 latency by T-cell activation. Cytokine (2007) 1.48
Human immunodeficiency virus type 1 Vpr induces DNA replication stress in vitro and in vivo. J Virol (2006) 1.47
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature (2010) 1.47
Ataxia telangiectasia mutated (ATM) modulates long interspersed element-1 (L1) retrotransposition in human neural stem cells. Proc Natl Acad Sci U S A (2011) 1.45
Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem (2006) 1.42
Naturally occurring fragments from two distinct regions of the prostatic acid phosphatase form amyloidogenic enhancers of HIV infection. J Virol (2011) 1.42
Nef is physically recruited into the immunological synapse and potentiates T cell activation early after TCR engagement. J Immunol (2005) 1.41
Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection). J Biol Chem (2009) 1.39
Slipping through the door: HIV entry into the nucleus. Microbes Infect (2002) 1.39
Human T-cell lymphotropic virus type 1 tax induction of biologically Active NF-kappaB requires IkappaB kinase-1-mediated phosphorylation of RelA/p65. J Biol Chem (2004) 1.38
Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe (2008) 1.35
HIV-1 virion fusion assay: uncoating not required and no effect of Nef on fusion. Virology (2004) 1.34
Activation of HIV transcription by the viral Tat protein requires a demethylation step mediated by lysine-specific demethylase 1 (LSD1/KDM1). PLoS Pathog (2011) 1.31
Fluorescence resonance energy transfer-based HIV-1 virion fusion assay. Methods Mol Biol (2004) 1.26
Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein. PLoS Pathog (2013) 1.23
A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs. PLoS One (2012) 1.23
Human immunodeficiency virus fusion to dendritic cells declines as cells mature. J Virol (2006) 1.22
A capping-independent function of MePCE in stabilizing 7SK snRNA and facilitating the assembly of 7SK snRNP. Nucleic Acids Res (2009) 1.21
NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity. Mol Cell Biol (2006) 1.20
The achilles heel of the trojan horse model of HIV-1 trans-infection. PLoS Pathog (2008) 1.18
Endogenous APOBEC3B restricts LINE-1 retrotransposition in transformed cells and human embryonic stem cells. J Biol Chem (2011) 1.18
Dynamic roles for NF-κB in HTLV-I and HIV-1 retroviral pathogenesis. Immunol Rev (2012) 1.14
Epigenetic control of retrotransposon expression in human embryonic stem cells. Mol Cell Biol (2010) 1.14
HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology (2002) 1.14
Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J Virol (2005) 1.13
Allelic heterogeneity in LINE-1 retrotransposition activity. Am J Hum Genet (2003) 1.13
Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology (2013) 1.12